A detailed history of Cwa Asset Management Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 25,676 shares of NVS stock, worth $2.65 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
25,676
Previous 18,485 38.9%
Holding current value
$2.65 Million
Previous $1.79 Million 65.16%
% of portfolio
0.16%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$106.13 - $120.89 $763,180 - $869,319
7,191 Added 38.9%
25,676 $2.95 Million
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $996,238 - $1.13 Million
10,457 Added 130.26%
18,485 $1.79 Million
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $740,743 - $815,163
8,028 New
8,028 $810,000
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $2.16 Million - $2.54 Million
-25,839 Closed
0 $0
Q4 2020

Feb 23, 2021

BUY
$78.07 - $94.43 $22,015 - $26,629
282 Added 1.1%
25,839 $2.44 Million
Q4 2020

Feb 09, 2021

BUY
$78.07 - $94.43 $47,466 - $57,413
608 Added 2.44%
25,557 $2.41 Million
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $240,916 - $266,903
2,933 Added 13.32%
24,949 $2.17 Million
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $99,705 - $112,235
-1,232 Reduced 5.3%
22,016 $1.92 Million
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $85,086 - $119,208
-1,204 Reduced 4.92%
23,248 $1.92 Million
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $4,723 - $5,340
-56 Reduced 0.23%
24,452 $2.32 Million
Q3 2019

Nov 14, 2019

BUY
$85.54 - $94.26 $334,803 - $368,933
3,914 Added 19.01%
24,508 $2.13 Million
Q2 2019

Aug 13, 2019

BUY
$75.4 - $92.8 $183,900 - $226,339
2,439 Added 13.43%
20,594 $1.88 Million
Q1 2019

May 14, 2019

BUY
$75.32 - $86.15 $897,663 - $1.03 Million
11,918 Added 191.09%
18,155 $1.75 Million
Q4 2018

Feb 14, 2019

BUY
$73.66 - $82.02 $459,417 - $511,558
6,237 New
6,237 $535,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cwa Asset Management Group, LLC Portfolio

Follow Cwa Asset Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwa Asset Management Group, LLC with notifications on news.